Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · IEX Real-Time Price · USD
28.31
-0.20 (-0.70%)
At close: May 24, 2024, 4:00 PM
28.98
+0.67 (2.37%)
After-hours: May 24, 2024, 4:28 PM EDT

IART Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 1994
Revenue
1,5421,5581,5421,3721,518
Upgrade
Revenue Growth (YoY)
-1.03%0.99%12.43%-9.60%3.06%
Upgrade
Cost of Revenue
656.84587.36597.81520.83564.68
Upgrade
Gross Profit
884.74970.31944.64851.03952.88
Upgrade
Selling, General & Admin
656.64616.32637.45594.53687.6
Upgrade
Research & Development
104.19101.1993.0577.3879.57
Upgrade
Other Operating Expenses
12.3813.8816.9127.7691.94
Upgrade
Operating Expenses
773.21731.39747.41699.66859.12
Upgrade
Operating Income
111.53238.92197.23151.3793.76
Upgrade
Interest Expense / Income
51.3849.5950.471.5853.96
Upgrade
Other Expense / Income
-20.92-24.57-67.84-13.73-20.3
Upgrade
Pretax Income
81.07213.89214.6893.5260.1
Upgrade
Income Tax
13.3333.3445.6-40.379.9
Upgrade
Net Income
67.74180.55169.08133.8950.2
Upgrade
Net Income Growth
-62.48%6.79%26.28%166.71%-17.43%
Upgrade
Shares Outstanding (Basic)
8083858586
Upgrade
Shares Outstanding (Diluted)
8084858586
Upgrade
Shares Change
-3.81%-2.30%0.30%-1.46%2.97%
Upgrade
EPS (Basic)
0.852.182.001.580.59
Upgrade
EPS (Diluted)
0.842.161.981.570.58
Upgrade
EPS Growth
-61.11%9.09%26.11%170.69%-19.44%
Upgrade
Free Cash Flow
73.09233.27264.41168.6161.93
Upgrade
Free Cash Flow Per Share
0.912.813.121.991.89
Upgrade
Gross Margin
57.39%62.29%61.24%62.03%62.79%
Upgrade
Operating Margin
7.23%15.34%12.79%11.03%6.18%
Upgrade
Profit Margin
4.39%11.59%10.96%9.76%3.31%
Upgrade
Free Cash Flow Margin
4.74%14.98%17.14%12.29%10.67%
Upgrade
Effective Tax Rate
16.44%15.59%21.24%-43.17%16.48%
Upgrade
EBITDA
258.15384.6388.74284.09228.58
Upgrade
EBITDA Margin
16.75%24.69%25.20%20.71%15.06%
Upgrade
Depreciation & Amortization
125.7121.12123.67118.99114.52
Upgrade
EBIT
132.45263.49265.07165.1114.06
Upgrade
EBIT Margin
8.59%16.92%17.19%12.03%7.52%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).